CVE-2020-14491

CVE-2020-14491 is a medium-severity vulnerability in Openclinic Ga Project Openclinic Ga with a CVSS 3.x base score of 6.5. It is not currently listed as actively exploited by CISA, and its EPSS exploit-prediction score is low. The underlying weakness is classified as CWE-862.

Key facts

Description

OpenClinic GA versions 5.09.02 and 5.89.05b do not properly check permissions before executing SQL queries, which may allow a low-privilege user to access privileged information.

Frequently asked questions

What is CVE-2020-14491?
OpenClinic GA versions 5.09.02 and 5.89.05b do not properly check permissions before executing SQL queries, which may allow a low-privilege user to access privileged information.
How severe is CVE-2020-14491?
CVE-2020-14491 has a CVSS 3.x base score of 6.5, rated medium severity. It is exploitable over network with low attack complexity, requires low privileges and no user interaction. Impact on confidentiality is high, integrity none, and availability none.
Is CVE-2020-14491 being actively exploited?
It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 1% (53rd percentile), an estimate of the probability of exploitation in the next 30 days.
What products are affected by CVE-2020-14491?
CVE-2020-14491 primarily affects Openclinic Ga Project Openclinic Ga. In total, 2 product configurations (CPEs) are listed as vulnerable; see the affected-products list for the exact versions.
How do I fix CVE-2020-14491?
Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround.
When was CVE-2020-14491 published?
CVE-2020-14491 was published on 2020-07-20 and last updated on 2026-06-17.

References

Affected products (2)

More vulnerabilities in Openclinic Ga Project Openclinic Ga

All CVEs affecting Openclinic Ga Project Openclinic Ga →

Other CWE-862 (Missing Authorization) vulnerabilities

Browse all CWE-862 (Missing Authorization) vulnerabilities →